Comprehensive structural analysis reveals broad-spectrum neutralizing antibodies against SARS-CoV-2 Omicron variants

被引:0
|
作者
Xiangyang Chi
Lingyun Xia
Guanying Zhang
Ximin Chi
Bangdong Huang
Yuanyuan Zhang
Zhengshan Chen
Jin Han
Liushu Wu
Zeya Li
Hancong Sun
Ping Huang
Changming Yu
Wei Chen
Qiang Zhou
机构
[1] Academy of Military Medical Sciences,Institute of Biotechnology
[2] Westlake University,Center for Infectious Disease Research, Westlake Laboratory of Life Sciences and Biomedicine, Key Laboratory of Structural Biology of Zhejiang Province, Institute of Biology, Westlake Institute for Advanced Study, School of Life Science
[3] Hangzhou,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The pandemic of COVID-19 caused by SARS-CoV-2 continues to spread around the world. Mutant strains of SARS-CoV-2 are constantly emerging. At present, Omicron variants have become mainstream. In this work, we carried out a systematic and comprehensive analysis of the reported spike protein antibodies, counting the epitopes and genotypes of these antibodies. We further comprehensively analyzed the impact of Omicron mutations on antibody epitopes and classified these antibodies according to their binding patterns. We found that the epitopes of the H-RBD class antibodies were significantly less affected by Omicron mutations than other classes. Binding and virus neutralization experiments showed that such antibodies could effectively inhibit the immune escape of Omicron. Cryo-EM results showed that this class of antibodies utilized a conserved mechanism to neutralize SARS-CoV-2. Our results greatly help us deeply understand the impact of Omicron mutations. Meanwhile, it also provides guidance and insights for developing Omicron antibodies and vaccines.
引用
收藏
相关论文
共 50 条
  • [1] Comprehensive structural analysis reveals broad-spectrum neutralizing antibodies against SARS-CoV-2 Omicron variants
    Chi, Xiangyang
    Xia, Lingyun
    Zhang, Guanying
    Chi, Ximin
    Huang, Bangdong
    Zhang, Yuanyuan
    Chen, Zhengshan
    Han, Jin
    Wu, Liushu
    Li, Zeya
    Sun, Hancong
    Huang, Ping
    Yu, Changming
    Chen, Wei
    Zhou, Qiang
    CELL DISCOVERY, 2023, 9 (01)
  • [2] Broad-spectrum humanized monoclonal neutralizing antibody against SARS-CoV-2 variants, including the Omicron variant
    Wen, Kun
    Cai, Jian-Piao
    Fan, Xiaodi
    Zhang, Xiaojuan
    Luo, Cuiting
    Tang, Kai-Ming
    Shuai, Huiping
    Chen, Lin-Lei
    Zhang, Ricky Ruiqi
    Situ, Jianwen
    Tsoi, Hoi-Wah
    Wang, Kun
    Chan, Jasper Fuk-Woo
    Yuan, Shuofeng
    Yuen, Kwok-Yung
    Zhou, Hongwei
    To, Kelvin Kai-Wang
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2023, 13
  • [3] Neutralizing antibodies and their cocktails against SARS-CoV-2 Omicron and other circulating variants
    Yang, Yang
    Du, Lanying
    CELLULAR & MOLECULAR IMMUNOLOGY, 2022, 19 (08) : 962 - 964
  • [4] Neutralizing antibodies and their cocktails against SARS-CoV-2 Omicron and other circulating variants
    Yang Yang
    Lanying Du
    Cellular & Molecular Immunology, 2022, 19 : 962 - 964
  • [5] Isolation of human monoclonal antibodies with neutralizing activity to a broad spectrum of SARS-CoV-2 viruses including the Omicron variants
    Ueno, Mikako
    Iwata-Yoshikawa, Naoko
    Matsunaga, Akihiro
    Okamura, Tadashi
    Saito, Sho
    Ashida, Shinobu
    Yoshida, Isao
    Nagashima, Mami
    Asakura, Hiroyuki
    Yaoita, Yuu
    Suzuki, Jun
    Sadamasu, Kenji
    Yoshimura, Kazuhisa
    Kutsuna, Satoshi
    Shiwa-Sudo, Nozomi
    Nagata, Noriyo
    Suzuki, Tadaki
    Suzuki, Akinori
    Okamoto, Miwa
    Kimura, Moto
    Ohmagari, Norio
    Miura, Ryu
    Ishizaka, Yukihito
    ANTIVIRAL RESEARCH, 2022, 201
  • [6] Converting non-neutralizing SARS-CoV-2 antibodies into broad-spectrum inhibitors
    Weidenbacher, Payton A. -B.
    Waltari, Eric
    de los Rios Kobara, Izumi
    Bell, Benjamin N.
    Morris, Mary Kate
    Cheng, Ya-Chen
    Hanson, Carl
    Pak, John E.
    Kim, Peter S.
    NATURE CHEMICAL BIOLOGY, 2022, 18 (11) : 1270 - +
  • [7] Converting non-neutralizing SARS-CoV-2 antibodies into broad-spectrum inhibitors
    Payton A.-B. Weidenbacher
    Eric Waltari
    Izumi de los Rios Kobara
    Benjamin N. Bell
    Mary Kate Morris
    Ya-Chen Cheng
    Carl Hanson
    John E. Pak
    Peter S. Kim
    Nature Chemical Biology, 2022, 18 : 1270 - 1276
  • [8] Comprehensive Overview of Broadly Neutralizing Antibodies against SARS-CoV-2 Variants
    Cui, Lingyan
    Li, Tingting
    Xue, Wenhui
    Zhang, Sibo
    Wang, Hong
    Liu, Hongjing
    Gu, Ying
    Xia, Ningshao
    Li, Shaowei
    VIRUSES-BASEL, 2024, 16 (06):
  • [9] Structural Characterization of a Neutralizing Nanobody With Broad Activity Against SARS-CoV-2 Variants
    Li, Tingting
    Zhou, Bingjie
    Luo, Zhipu
    Lai, Yanling
    Huang, Suqiong
    Zhou, Yuanze
    Li, Yaning
    Gautam, Anupriya
    Bourgeau, Salome
    Wang, Shurui
    Bao, Juan
    Tan, Jingquan
    Lavillette, Dimitri
    Li, Dianfan
    FRONTIERS IN MICROBIOLOGY, 2022, 13
  • [10] Broadly neutralizing antibodies against SARS-CoV-2 variants
    Linqi Zhang
    National Science Open, 2022, 1 (01) : 24 - 31